Study objective -To ascertain if agricultural workers in the Republic of Ireland had a higher than expected mortality from brain and haematopoietic cancers than occurred in the general population.
increased. The increase in reported mortality of these haematopoietic cancers in farmers was no greater and in other agricultural workers it was less than in the general population. Conclusion -There was no evidence that farmers had any greater increase in mortality from these cancers than the general population. The An investigation in 1985 into the causes of death in male research and technical staff employed by the Agricultural Institute of Ireland, showed that there were four deaths from primary brain cancer, three from leukaemia, and one from Hodgkin's disease among the 11 deaths from cancer out of 28 total deaths.'
Another member of the Institute's technical staff was suffering from a lymphatic cancer. The cluster of deaths from brain and haematopoietic cancers among the research and technical staff, who had worked in different branches of the Institute, could have been due to radiation from radioactive isotopes, a viral infection, or a chemical hazard from some substance used in agriculture or research, or it could have been a very unusual chance occurrence.
About the same time it was reported that a cluster of rare cancers (sarcoma, lymphoma) was occurring among laboratory workers at the Pasteur Institute in Paris; a follow up study showed an excess of bone, pancreas and brain cancer deaths but the numbers were small ( reflected by any increase in these cancer groups among farmers in general in Ireland. It is still possible that there may be a subgroup of farmers that have a higher than normal risk of developing these cancers, but whatever the cause of the clusters of deaths from these cancers among research workers, there is no greater risk of developing these cancers in the general population of farmers in Ireland than occurs in the population as a whole.
Further studies are being undertaken at an international level to ascertain if research workers are subject to any undue risks of cancer associated with their work and, if there is such a risk, to ascertain what it is so that it can be avoided. As suggested by Rutty et al and also by an editorial in the Lancet,9 there are good reasons why a register of the causes of death of laboratory workers should be compiled in a number of countries. A retrospective cohort study of personnel employed over the past 20 years in biomedical or agronomic research institutes in Europe has now been set up under the aegis of the International Agency for Research in Cancer (IARC), Lyon.10
